Niagen Bioscience (NAGE) Free cash flow

annual FCF:

$11.95M+$4.98M(+71.42%)
December 1, 2024

Summary

  • As of today (June 17, 2025), NAGE annual free cash flow is $11.95 million, with the most recent change of +$4.98 million (+71.42%) on December 1, 2024.
  • During the last 3 years, NAGE annual FCF has risen by +$36.52 million (+148.62%).
  • NAGE annual FCF is now at all-time high.

Performance

NAGE Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

quarterly FCF:

$7.85M-$663.00K(-7.79%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE quarterly free cash flow is $7.85 million, with the most recent change of -$663.00 thousand (-7.79%) on March 1, 2025.
  • Over the past year, NAGE quarterly FCF has increased by +$7.60 million (+2990.94%).
  • NAGE quarterly FCF is now -7.79% below its all-time high of $8.51 million, reached on December 1, 2024.

Performance

NAGE quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

TTM FCF:

$19.54M+$7.60M(+63.59%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE TTM free cash flow is $19.54 million, with the most recent change of +$7.60 million (+63.59%) on March 1, 2025.
  • Over the past year, NAGE TTM FCF has increased by +$15.02 million (+332.18%).
  • NAGE TTM FCF is now at all-time high.

Performance

NAGE TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

NAGE Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.4%+2990.9%+332.2%
3 y3 years+148.6%+208.7%+174.2%
5 y5 years+156.4%+249.9%+224.6%

NAGE Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+148.6%-7.8%+300.4%at high+188.4%
5 y5-yearat high+148.6%-7.8%+196.2%at high+174.2%
alltimeall timeat high+148.6%-7.8%+186.4%at high+174.2%

NAGE Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$7.85M(-7.8%)
$19.54M(+63.6%)
Dec 2024
$11.95M(+71.4%)
$8.51M(+146.5%)
$11.95M(+194.2%)
Sep 2024
-
$3.45M(-1351.4%)
$4.06M(+316.0%)
Jun 2024
-
-$276.00K(-208.7%)
$976.00K(-78.4%)
Mar 2024
-
$254.00K(-59.6%)
$4.52M(-35.1%)
Dec 2023
$6.97M(-145.2%)
$628.00K(+69.7%)
$6.97M(+19.3%)
Sep 2023
-
$370.00K(-88.7%)
$5.84M(+247.9%)
Jun 2023
-
$3.27M(+21.1%)
$1.68M(-130.5%)
Mar 2023
-
$2.70M(-640.2%)
-$5.51M(-64.3%)
Dec 2022
-$15.43M(-37.2%)
-$500.00K(-86.8%)
-$15.43M(-22.4%)
Sep 2022
-
-$3.79M(-3.2%)
-$19.88M(-10.1%)
Jun 2022
-
-$3.92M(-45.8%)
-$22.10M(-16.1%)
Mar 2022
-
-$7.22M(+46.0%)
-$26.34M(+7.2%)
Dec 2021
-$24.57M(+128.7%)
-$4.95M(-17.8%)
-$24.57M(+25.5%)
Sep 2021
-
-$6.01M(-26.3%)
-$19.58M(+12.1%)
Jun 2021
-
-$8.16M(+49.7%)
-$17.47M(+59.4%)
Mar 2021
-
-$5.45M(<-9900.0%)
-$10.96M(+2.0%)
Dec 2020
-$10.74M(-49.3%)
$45.00K(-101.2%)
-$10.74M(-8.0%)
Sep 2020
-
-$3.90M(+136.8%)
-$11.68M(-25.6%)
Jun 2020
-
-$1.65M(-68.5%)
-$15.69M(-32.2%)
Mar 2020
-
-$5.24M(+488.3%)
-$23.13M(+9.1%)
Dec 2019
-$21.19M(-5.2%)
-$890.00K(-88.8%)
-$21.19M(-17.0%)
Sep 2019
-
-$7.92M(-12.9%)
-$25.53M(+11.3%)
Jun 2019
-
-$9.09M(+175.7%)
-$22.94M(+6.6%)
Mar 2019
-
-$3.30M(-37.0%)
-$21.51M(-3.8%)
Dec 2018
-$22.36M(+100.4%)
-$5.23M(-1.6%)
-$22.36M(+5.5%)
Sep 2018
-
-$5.32M(-30.6%)
-$21.19M(+25.2%)
Jun 2018
-
-$7.66M(+84.6%)
-$16.93M(+13.5%)
Mar 2018
-
-$4.15M(+2.2%)
-$14.91M(+33.6%)
Dec 2017
-$11.15M(+139.3%)
-$4.06M(+286.1%)
-$11.15M(+49.1%)
Sep 2017
-
-$1.05M(-81.4%)
-$7.48M(+2.6%)
Jun 2017
-
-$5.64M(+1321.7%)
-$7.29M(+242.1%)
Mar 2017
-
-$397.00K(+2.4%)
-$2.13M(-54.3%)
Dec 2016
-$4.66M
-$387.80K(-54.9%)
-$4.66M(-14.1%)
Sep 2016
-
-$860.20K(+77.0%)
-$5.42M(-1.6%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$485.90K(-83.4%)
-$5.51M(+10.4%)
Mar 2016
-
-$2.93M(+154.4%)
-$4.99M(+81.0%)
Dec 2015
-$2.76M(-2.6%)
-$1.15M(+21.3%)
-$2.76M(+40.5%)
Sep 2015
-
-$949.00K(-2975.8%)
-$1.96M(+35.3%)
Jun 2015
-
$33.00K(-104.8%)
-$1.45M(-30.9%)
Mar 2015
-
-$691.80K(+94.7%)
-$2.10M(-25.8%)
Dec 2014
-$2.83M(-31.5%)
-$355.40K(-18.6%)
-$2.83M(-33.4%)
Sep 2014
-
-$436.60K(-29.2%)
-$4.25M(+6.0%)
Jun 2014
-
-$617.10K(-56.6%)
-$4.01M(-16.5%)
Mar 2014
-
-$1.42M(-19.7%)
-$4.80M(+16.2%)
Dec 2013
-$4.13M(-59.5%)
-$1.77M(+810.9%)
-$4.13M(+32.4%)
Sep 2013
-
-$194.60K(-86.2%)
-$3.12M(-21.9%)
Jun 2013
-
-$1.41M(+87.4%)
-$4.00M(-36.4%)
Mar 2013
-
-$753.20K(-1.0%)
-$6.29M(-38.3%)
Dec 2012
-$10.20M(+138.5%)
-$760.60K(-28.9%)
-$10.20M(-7.8%)
Sep 2012
-
-$1.07M(-71.1%)
-$11.06M(-3.5%)
Jun 2012
-
-$3.70M(-20.6%)
-$11.46M(+25.6%)
Mar 2012
-
-$4.66M(+186.9%)
-$9.13M(+113.5%)
Dec 2011
-$4.28M(+49.5%)
-$1.63M(+10.4%)
-$4.28M(+20.7%)
Sep 2011
-
-$1.47M(+7.7%)
-$3.54M(+44.0%)
Jun 2011
-
-$1.37M(-824.7%)
-$2.46M(-10.6%)
Mar 2011
-
$188.60K(-121.2%)
-$2.75M(-3.9%)
Dec 2010
-$2.86M(+392.6%)
-$891.20K(+129.0%)
-$2.86M(+44.2%)
Sep 2010
-
-$389.20K(-76.5%)
-$1.98M(+18.2%)
Jun 2010
-
-$1.66M(-2231.1%)
-$1.68M(+597.7%)
Mar 2010
-
$77.80K(-655.7%)
-$240.50K(-58.6%)
Dec 2009
-$580.70K(-76.0%)
-$14.00K(-83.3%)
-$580.70K(+2.5%)
Sep 2009
-
-$83.70K(-62.1%)
-$566.70K(+17.3%)
Jun 2009
-
-$220.60K(-15.9%)
-$483.00K(+84.1%)
Mar 2009
-
-$262.40K(<-9900.0%)
-$262.40K(+913.1%)
Dec 2008
-$2.42M(+6178.4%)
-
-
Feb 2008
-
$0.00(-100.0%)
-$25.90K(-32.7%)
Nov 2007
-$38.50K
-$3600.00(-16.3%)
-$38.50K(+10.3%)
Aug 2007
-
-$4300.00(-76.1%)
-$34.90K(+14.1%)
May 2007
-
-$18.00K(+42.9%)
-$30.60K(+142.9%)
Feb 2007
-
-$12.60K
-$12.60K

FAQ

  • What is Niagen Bioscience annual free cash flow?
  • What is the all time high annual FCF for Niagen Bioscience?
  • What is Niagen Bioscience annual FCF year-on-year change?
  • What is Niagen Bioscience quarterly free cash flow?
  • What is the all time high quarterly FCF for Niagen Bioscience?
  • What is Niagen Bioscience quarterly FCF year-on-year change?
  • What is Niagen Bioscience TTM free cash flow?
  • What is the all time high TTM FCF for Niagen Bioscience?
  • What is Niagen Bioscience TTM FCF year-on-year change?

What is Niagen Bioscience annual free cash flow?

The current annual FCF of NAGE is $11.95M

What is the all time high annual FCF for Niagen Bioscience?

Niagen Bioscience all-time high annual free cash flow is $11.95M

What is Niagen Bioscience annual FCF year-on-year change?

Over the past year, NAGE annual free cash flow has changed by +$4.98M (+71.42%)

What is Niagen Bioscience quarterly free cash flow?

The current quarterly FCF of NAGE is $7.85M

What is the all time high quarterly FCF for Niagen Bioscience?

Niagen Bioscience all-time high quarterly free cash flow is $8.51M

What is Niagen Bioscience quarterly FCF year-on-year change?

Over the past year, NAGE quarterly free cash flow has changed by +$7.60M (+2990.94%)

What is Niagen Bioscience TTM free cash flow?

The current TTM FCF of NAGE is $19.54M

What is the all time high TTM FCF for Niagen Bioscience?

Niagen Bioscience all-time high TTM free cash flow is $19.54M

What is Niagen Bioscience TTM FCF year-on-year change?

Over the past year, NAGE TTM free cash flow has changed by +$15.02M (+332.18%)
On this page